查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532222

融合切片市場：2024-2033年全球產業分析、規模、佔有率、成長、趨勢、預測

Fusion Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球融合切片市場（2024-2033）的綜合報告。本報告對關鍵市場動態進行了詳細評估，包括驅動因素、趨勢、機會和挑戰，並對市場結構提供了深入的見解。

關鍵見解

  • 融合切片市場規模（2024年）：9.998億美元
  • 預測市場規模（2033年）：295.174億美元
  • 全球市場成長率（2024-2033年年複合成長率）：45.7%

融合切片市場 - 研究範圍

融合切片是一種突破性的醫療程序，它將 MRI 和超音波成像相結合，對前列腺組織進行更精確、更有針對性的切片。該技術對於檢測和診斷前列腺癌特別有用，比傳統切片方法具有更高的準確性。該市場包括醫院、診斷中心和專科診所使用的各種融合切片系統、軟體和設備。前列腺癌盛行率的不斷上升、影像技術的進步以及人們對癌症早期檢測的認識不斷提高，推動了市場的成長。

推動市場成長的因素：

全球融合切片市場由幾個關鍵因素驅動，包括前列腺癌發病率的上升以及傳統切片方法在準確診斷方面的局限性。診斷影像和切片技術的技術進步，例如 MRI 和超音波的集成，顯著提高了診斷準確性並支持了市場擴張。人們對微創手術的偏好日益增加，加上人們對早期發現癌症的好處的認識不斷提高，進一步推動了市場的成長。此外，用於更有效切片引導的複雜軟體和成像系統的開發也為市場發展提供了新的機會。

市場限制因素：

儘管成長前景廣闊，但融合切片市場面臨著與先進切片系統的高成本以及對醫療保健專業人員進行專門培訓的需求相關的挑戰。在資源匱乏的環境中，融合切片程序的取得機會有限以及技術複雜性也可能阻礙市場成長。此外，一些地區的償付問題和監管挑戰也可能影響市場採用。解決這些問題需要開發具有成本效益的解決方案、改進培訓計劃和強有力的監管框架，以確保融合切片技術的廣泛使用。

市場機會：

由於技術創新和不斷發展的醫療服務模式，融合切片市場帶來了巨大的機會。攜帶式、易於使用的融合切片系統的發展，加上人工智慧和機器學習的進步，為更準確、更有效率的癌症診斷提供了潛力。遠距醫療和行動醫療應用的擴展為患者管理和支援提供了新的途徑。此外，個人化醫療和精準診斷研究的進步將開闢新的細分市場並促進創新。策略合作夥伴關係、研發投資以及採用具成本效益的解決方案對於利用新機會和維持市場領先地位非常重要。

本報告解決的關鍵問題

  • 推動融合切片市場全球成長的關鍵因素是什麼？
  • 哪些技術和方法引領融合切片的採用？
  • 技術進步如何影響融合切片市場的競爭格局？
  • 誰是融合切片市場的主要參與者？ 他們保持競爭力的策略是什麼？
  • 全球融合切片市場的新趨勢和未來前景是什麼？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制

第3章 市場風險與趨勢評估

  • 風險評估
    • COVID-19 危機及其對融合切片需求的影響
    • 與過去的危機相比，對新冠肺炎（COVID-19）的影響進行基準測試
    • 對市值的影響（百萬美元）
    • 評估：依主要國家劃分
    • 評估：依主要細分市場
    • 針對供應商的行動要點和建議
  • 影響市場的主要趨勢
  • 配方和產品開發的趨勢

第4章 市場背景與基本資料點

  • 全球融合切片市場（百萬美元）
  • 融合切片市場機會評估（百萬美元）
    • 市場總規模
    • 提供服務的可尋址市場規模
    • 提供服務的可用市場規模
  • 市場情境預測
    • 樂觀情況下的需求
    • 預期情況下的需求
    • 保守情境下的需求
  • 投資可行性分析
    • 投資成熟市場
    • 投資新興市場
  • 預測因子 - 相關性和影響
    • 主要公司過去的發展
    • 全球融合切片市場的成長
    • 融合切片採用率：依國家劃分
  • 市場動態
    • 市場驅動因素與影響評估
    • 主要市場挑戰與影響評估
    • 融合切片市場機會
    • 世界市場的重要趨勢及其影響評估

第5章 關鍵成功因素

  • 製造商致力於滲透率低但成長率高的市場
  • 投資具有高增量機會的細分市場
  • 同業基準

第6章 全球融合切片市場需求分析

  • 過去的市場分析，2019-2023年
  • 2024-2033年當前與未來市場預測
  • 年成長趨勢分析

第7章 全球融合切片市場價值分析

  • 2019-2023年過去的市值（百萬美元）分析
  • 2024-2033年當前及未來市場價值（百萬美元）預測
    • 年成長趨勢分析
    • 絕對數量機會分析

第8章 全球融合切片市場分析：依切片途徑

  • 簡介/主要發現
  • 歷史市場規模（百萬美元）分析：按切片路線技術，2019-2023年
  • 2024-2033年 Biopsy Route Technology 當前和未來市場規模（百萬美元）的分析和預測
    • 經會陰
    • 經直腸
  • 市場吸引力分析：依切片途徑技術

第9章 全球融合切片市場分析：依最終用途劃分

  • 簡介/主要發現
  • 2019-2023年以最終用途劃分的歷史市場規模（百萬美元）分析
  • 2024-2033年依最終用途劃分的當前和未來市場規模（百萬美元）的分析和預測
    • 醫院
    • 診斷中心
    • 門診手術中心
  • 市場吸引力分析：依最終用途分類

第10章 依地區劃分的全球融合切片市場分析

  • 簡介
  • 2019-2023年依地區歷史市場規模分析（百萬美元）
  • 目前市場規模（百萬美元）以及2024-2033年依地區分析和預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東和非洲（MEA）
  • 區域市場吸引力分析

第11章 北美融合切片市場分析

第12章 拉丁美洲融合切片市場分析

第13章 歐洲融合切片市場分析

第14章 亞太融合切片市場分析

第15章 中東與非洲融合切片市場分析

第16章 主要國家融合切片市場分析

  • 簡介
    • 市值比分析：依主要國家分類
    • 世界與各國成長比較
  • 美國融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 加拿大融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 墨西哥融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 巴西融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 德國融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 法國融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 義大利融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 比荷盧融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 英國融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 北歐國家融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 中國融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 日本融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 韓國融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • GCC國家融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 南非融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
  • 土耳其融合切片市場分析
    • 金額比例分析：依市場分類
    • 金額/分析與預測：按市場分類，2019-2033年
    • 國內競爭情勢及企業集中度

第17章 市場結構分析

  • 市場分析：依公司層級
  • 市場集中度
  • 主要公司市佔率分析
  • 市場現況分析

第18章 競爭分析

  • 競爭對手儀表板
  • 競爭基準
  • 競爭詳情
    • MedCom
    • ESAOTE SPA
    • KOELIS
    • Focal Healthcare
    • GeoScan Medical
    • UC-Care Medical Systems Ltd.

第19章 使用的先決條件與縮寫

第20章 研究方法

簡介目錄
Product Code: PMRREP33279

Persistence Market Research has recently released a comprehensive report on the global Fusion Biopsy Market (2024-2033). This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Fusion Biopsy Market Size (2024E): USD 999.8 Mn
  • Projected Market Value (2033F): USD 29,517.4 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 45.7%

Fusion Biopsy Market - Report Scope:

Fusion biopsy is a groundbreaking medical procedure that combines MRI and ultrasound imaging to provide more accurate and targeted biopsy of prostate tissues. This technique is particularly beneficial in detecting and diagnosing prostate cancer, offering improved precision over traditional biopsy methods. The market encompasses various fusion biopsy systems, software, and devices used in hospitals, diagnostic centers, and specialty clinics. Market growth is driven by increasing prevalence of prostate cancer, advancements in imaging technologies, and growing awareness about early cancer detection.

Market Growth Drivers:

The global fusion biopsy market is propelled by several key factors, including the rising incidence of prostate cancer and the limitations of traditional biopsy methods in accurately diagnosing the disease. Technological advancements in imaging and biopsy techniques, such as the integration of MRI with ultrasound, are significantly enhancing diagnostic precision, thereby driving market expansion. The increasing preference for minimally invasive procedures, coupled with growing awareness about the benefits of early cancer detection, further stimulates market growth. Additionally, the development of sophisticated software and imaging systems for more effective biopsy guidance provides new opportunities for market development.

Market Restraints:

Despite the promising growth prospects, the fusion biopsy market faces challenges related to the high costs of advanced biopsy systems and the need for specialized training for healthcare professionals. Limited access to fusion biopsy procedures in low-resource settings and the complexity of the technology can also hinder market growth. Additionally, reimbursement issues and regulatory challenges in some regions may impact market adoption. Addressing these issues requires the development of cost-effective solutions, improved training programs, and robust regulatory frameworks to ensure the widespread adoption of fusion biopsy technologies.

Market Opportunities:

The fusion biopsy market presents significant opportunities driven by technological innovations and evolving healthcare delivery models. The development of portable and user-friendly fusion biopsy systems, coupled with advancements in artificial intelligence and machine learning, offers the potential for more precise and efficient cancer diagnosis. The expansion of telemedicine and mobile health applications provides new avenues for patient management and support. Moreover, increasing research into personalized medicine and precision diagnostics opens up new market segments and drives innovation. Strategic partnerships, investments in R&D, and the introduction of cost-effective solutions are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the fusion biopsy market globally?
  • Which technologies and approaches are leading the adoption of fusion biopsy procedures?
  • How are technological advancements influencing the competitive landscape of the fusion biopsy market?
  • Who are the key players in the fusion biopsy market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global fusion biopsy market?

Competitive Intelligence and Business Strategy:

Leading players in the global fusion biopsy market, including Medtronic Plc, Siemens Healthineers, and Koninklijke Philips N.V., focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced biopsy systems and integrated imaging technologies. Collaborations with research institutions, healthcare providers, and academic centers facilitate market access and promote new technology adoption. Emphasis on clinical research, public education, and comprehensive support services fosters market growth and enhances diagnostic outcomes in the evolving fusion biopsy landscape.

Key Companies Profiled:

  • Eigen
  • Koninklijke Philips N.V.
  • Hitachi Ltd.
  • MedCom
  • ESAOTE SPA
  • KOELIS
  • Focal Healthcare
  • GeoScan Medical
  • UC-Care Medical Systems Ltd.

Fusion Biopsy Industry Segmentation

By Biopsy Route

  • Transperineal
  • Transrectal

By End Use

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Summary of Statistics
  • 1.3. Key Market Characteristics & Attributes
  • 1.4. Persistence Market Research Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

  • 3.1. Risk Assessment
    • 3.1.1. COVID-19 Crisis and Impact on Fusion Biopsy Demand
    • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
    • 3.1.3. Impact on Market Value (US$ Mn)
    • 3.1.4. Assessment by Key Countries
    • 3.1.5. Assessment by Key Market Segments
    • 3.1.6. Action Points and Recommendation for Suppliers
  • 3.2. Key Trends Impacting the Market
  • 3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

  • 4.1. Global Fusion Biopsy Market (US$ Mn)
  • 4.2. Fusion Biopsy Market Opportunity Assessment (US$ Mn)
    • 4.2.1. Total Available Market
    • 4.2.2. Serviceable Addressable Market
    • 4.2.3. Serviceable Obtainable Market
  • 4.3. Market Scenario Forecast
    • 4.3.1. Demand in optimistic Scenario
    • 4.3.2. Demand in Likely Scenario
    • 4.3.3. Demand in Conservative Scenario
  • 4.4. Investment Feasibility Analysis
    • 4.4.1. Investment in Established Markets
      • 4.4.1.1. In Short Term
      • 4.4.1.2. In Long Term
    • 4.4.2. Investment in Emerging Markets
      • 4.4.2.1. In Short Term
      • 4.4.2.2. In Long Term
  • 4.5. Forecast Factors - Relevance & Impact
    • 4.5.1. Top Companies Historical Growth
    • 4.5.2. Global Fusion Biopsy Market Growth
    • 4.5.3. Fusion Biopsy Adoption Rate, By Country
  • 4.6. Market Dynamics
    • 4.6.1. Market Driving Factors and Impact Assessment
    • 4.6.2. Prominent Market Challenges and Impact Assessment
    • 4.6.3. Fusion Biopsy Market Opportunities
    • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

  • 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
  • 5.2. Banking on with Segments High Incremental Opportunity
  • 5.3. Peer Benchmarking

6. Global Fusion Biopsy Market Demand Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Analysis, 2019-2023
  • 6.2. Current and Future Market Projections, 2024-2033
  • 6.3. Y-o-Y Growth Trend Analysis

7. Global Fusion Biopsy Market Value Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Fusion Biopsy Market Analysis 2019-2023 and Forecast 2024-2033, By Biopsy Route

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Biopsy Route Technique, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Biopsy Route Technique, 2024-2033
    • 8.3.1. Transperineal
    • 8.3.2. Transrectal
  • 8.4. Market Attractiveness Analysis By Biopsy Route Technique

9. Global Fusion Biopsy Market Analysis 2019-2023 and Forecast 2024-2033, By End-Use

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End-Use, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-Use, 2024-2033
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Ambulatory Surgery Centers
  • 9.4. Market Attractiveness Analysis By End-Use

10. Global Fusion Biopsy Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. Asia Pacific
    • 10.3.5. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Fusion Biopsy Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2033
    • 11.4.1. By Country
      • 11.4.1.1. U.S.
      • 11.4.1.2. Canada
      • 11.4.1.3. Rest of North America
    • 11.4.2. By Biopsy Route Technique
    • 11.4.3. By End-Use
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Biopsy Route Technique
    • 11.5.3. By End-Use

12. Latin America Fusion Biopsy Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2033
    • 12.4.1. By Country
      • 12.4.1.1. Brazil
      • 12.4.1.2. Mexico
      • 12.4.1.3. Rest of Latin America
    • 12.4.2. By Biopsy Route Technique
    • 12.4.3. By End-Use
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Biopsy Route Technique
    • 12.5.3. By End-Use

13. Europe Fusion Biopsy Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2033
    • 13.4.1. By Country
      • 13.4.1.1. Germany
      • 13.4.1.2. France
      • 13.4.1.3. U.K.
      • 13.4.1.4. Italy
      • 13.4.1.5. Benelux
      • 13.4.1.6. Nordic Countries
      • 13.4.1.7. Rest of Europe
    • 13.4.2. By Biopsy Route Technique
    • 13.4.3. By End-Use
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Biopsy Route Technique
    • 13.5.3. By End-Use

14. Asia Pacific Fusion Biopsy Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. China
      • 14.4.1.2. Japan
      • 14.4.1.3. South Korea
      • 14.4.1.4. Rest of Asia Pacific
    • 14.4.2. By Biopsy Route Technique
    • 14.4.3. By End-Use
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Biopsy Route Technique
    • 14.5.3. By End-Use

15. Middle East and Africa Fusion Biopsy Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. GCC Countries
      • 15.4.1.2. South Africa
      • 15.4.1.3. Turkey
      • 15.4.1.4. Rest of Middle East and Africa
    • 15.4.2. By Biopsy Route Technique
    • 15.4.3. By End-Use
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Biopsy Route Technique
    • 15.5.3. By End-Use

16. Key Countries Fusion Biopsy Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
    • 16.1.1. Market Value Proportion Analysis, By Key Countries
    • 16.1.2. Global Vs. Country Growth Comparison
  • 16.2. US Fusion Biopsy Market Analysis
    • 16.2.1. Value Proportion Analysis by Market Taxonomy
    • 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.2.2.1. By Biopsy Route Technique
      • 16.2.2.2. By End-Use
  • 16.3. Canada Fusion Biopsy Market Analysis
    • 16.3.1. Value Proportion Analysis by Market Taxonomy
    • 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.3.2.1. By Biopsy Route Technique
      • 16.3.2.2. By End-Use
  • 16.4. Mexico Fusion Biopsy Market Analysis
    • 16.4.1. Value Proportion Analysis by Market Taxonomy
    • 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.4.2.1. By Biopsy Route Technique
      • 16.4.2.2. By End-Use
  • 16.5. Brazil Fusion Biopsy Market Analysis
    • 16.5.1. Value Proportion Analysis by Market Taxonomy
    • 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.5.2.1. By Biopsy Route Technique
      • 16.5.2.2. By End-Use
  • 16.6. Germany Fusion Biopsy Market Analysis
    • 16.6.1. Value Proportion Analysis by Market Taxonomy
    • 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.6.2.1. By Biopsy Route Technique
      • 16.6.2.2. By End-Use
  • 16.7. France Fusion Biopsy Market Analysis
    • 16.7.1. Value Proportion Analysis by Market Taxonomy
    • 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.7.2.1. By Biopsy Route Technique
      • 16.7.2.2. By End-Use
  • 16.8. Italy Fusion Biopsy Market Analysis
    • 16.8.1. Value Proportion Analysis by Market Taxonomy
    • 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.8.2.1. By Biopsy Route Technique
      • 16.8.2.2. By End-Use
  • 16.9. BENELUX Fusion Biopsy Market Analysis
    • 16.9.1. Value Proportion Analysis by Market Taxonomy
    • 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.9.2.1. By Biopsy Route Technique
      • 16.9.2.2. By End-Use
  • 16.10. UK Fusion Biopsy Market Analysis
    • 16.10.1. Value Proportion Analysis by Market Taxonomy
    • 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.10.2.1. By Biopsy Route Technique
      • 16.10.2.2. By End-Use
  • 16.11. Nordic Countries Fusion Biopsy Market Analysis
    • 16.11.1. Value Proportion Analysis by Market Taxonomy
    • 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.11.2.1. By Biopsy Route Technique
      • 16.11.2.2. By End-Use
  • 16.12. China Fusion Biopsy Market Analysis
    • 16.12.1. Value Proportion Analysis by Market Taxonomy
    • 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.12.2.1. By Biopsy Route Technique
      • 16.12.2.2. By End-Use
  • 16.13. Japan Fusion Biopsy Market Analysis
    • 16.13.1. Value Proportion Analysis by Market Taxonomy
    • 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.13.2.1. By Biopsy Route Technique
      • 16.13.2.2. By End-Use
  • 16.14. South Korea Fusion Biopsy Market Analysis
    • 16.14.1. Value Proportion Analysis by Market Taxonomy
    • 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.14.2.1. By Biopsy Route Technique
      • 16.14.2.2. By End-Use
  • 16.15. GCC Countries Fusion Biopsy Market Analysis
    • 16.15.1. Value Proportion Analysis by Market Taxonomy
    • 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.15.2.1. By Biopsy Route Technique
      • 16.15.2.2. By End-Use
  • 16.16. South Africa Fusion Biopsy Market Analysis
    • 16.16.1. Value Proportion Analysis by Market Taxonomy
    • 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.16.2.1. By Biopsy Route Technique
      • 16.16.2.2. By End-Use
  • 16.17. Turkey Fusion Biopsy Market Analysis
    • 16.17.1. Value Proportion Analysis by Market Taxonomy
    • 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 16.17.2.1. By Biopsy Route Technique
      • 16.17.2.2. By End-Use
    • 16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

  • 17.1. Market Analysis by Tier of Companies
  • 17.2. Market Concentration
  • 17.3. Market Share Analysis of Top Players
  • 17.4. Market Presence Analysis
    • 17.4.1. By Regional footprint of Players
    • 17.4.2. Product footprint by Players

18. Competition Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Competition Deep Dive
    • 18.3.1. MedCom
      • 18.3.1.1. Overview
      • 18.3.1.2. Product Portfolio
      • 18.3.1.3. Sales Footprint
      • 18.3.1.4. Strategy Overview
    • 18.3.2. ESAOTE SPA
      • 18.3.2.1. Overview
      • 18.3.2.2. Product Portfolio
      • 18.3.2.3. Sales Footprint
      • 18.3.2.4. Strategy Overview
    • 18.3.3. KOELIS
      • 18.3.3.1. Overview
      • 18.3.3.2. Product Portfolio
      • 18.3.3.3. Sales Footprint
      • 18.3.3.4. Strategy Overview
    • 18.3.4. Focal Healthcare
      • 18.3.4.1. Overview
      • 18.3.4.2. Product Portfolio
      • 18.3.4.3. Sales Footprint
      • 18.3.4.4. Strategy Overview
    • 18.3.5. GeoScan Medical
      • 18.3.5.1. Overview
      • 18.3.5.2. Product Portfolio
      • 18.3.5.3. Sales Footprint
      • 18.3.5.4. Strategy Overview
    • 18.3.6. UC-Care Medical Systems Ltd.
      • 18.3.6.1. Overview
      • 18.3.6.2. Product Portfolio
      • 18.3.6.3. Sales Footprint
      • 18.3.6.4. Strategy Overview

19. Assumptions and Acronyms Used

20. Research Methodology